Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
- Michael D. Keller
- , Patrick J. Hanley
- , Yueh Yun Chi
- , Paibel Aguayo-Hiraldo
- , Christopher C. Dvorak
- , Michael R. Verneris
- , Donald B. Kohn
- , Sung Yun Pai
- , Blachy J. Dávila Saldaña
- , Benjamin Hanisch
- , Troy C. Quigg
- , Roberta H. Adams
- , Ann Dahlberg
- , Shanmuganathan Chandrakasan
- , Hasibul Hasan
- , Jemily Malvar
- , Mariah A. Jensen-Wachspress
- , Christopher A. Lazarski
- , Gelina Sani
- , John M. Idso
- Division of Hematology & Oncology
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Immunology
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- Institute of Clinical and Translational Sciences (ICTS)
- Bursky Center for Human Immunology and Immunotherapy
- Siteman Cancer Center
Research output: Contribution to journal › Article › peer-review
26
Link opens in a new tab
Scopus
citations